跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
ANSTO Health Sodium Iodide (131-I) Therapy Capsules 50MBq - 6000MBq vials
Approved
STANDARD
ANSTO Health Sodium Iodide (131-I) Therapy Capsules 50MBq - 6000MBq vials
Australian Nuclear Science and Technology Organisation T/A ANSTO
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
6b6aacf6e0b1d85f
Company
Australian Nuclear Science and Technology Organisation T/A ANSTO
Type
Standard
Approval Details
Approval Id
6b6aacf6e0b1d85f
Product Name
ANSTO Health Sodium Iodide (131-I) Therapy Capsules 50MBq - 6000MBq vials
Artg Id
22808
Artg Name
AUSTRALIAN RADIOISOTOPES Sodium Iodide (I-131) 50 - 6000MBq Therapy Capsule vial
Sponsor
Australian Nuclear Science and Technology Organisation T/A ANSTO
Company Detail Path
/organization/australian-nuclear-science-and-technology-organisation-lucas-heights-new-south-wales-australia
Artg Date
1991-10-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2011-CMI-01504-3
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2011-PI-01083-3
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
6b6aacf6e0b1d85f
Type
Standard
Back to TGA Approvals
ANSTO Health Sodium Iodide (131-I) Therapy Capsules 50MBq - 6000MBq vials - TGA Drug Approval Details